The multinational company builds, integrates and operates businesses in pharmaceutical cannabis markets.
Southern Cannabis Holdings’ director and chief executive officer Tim Drury is set to present at Proactive’s medical cannabis virtual investor conference on Tuesday, August 11 at 12pm AEST (10am AWST).
Drury will outline the company’s plans to build, integrate and operate high value brands domestically and globally across the cannabis value chain.
- Cannabis Access Clinics – Australia’s first and largest network of medicinal cannabis clinics;
- Applied Cannabis Research – A specialist contract research organisation dedicated to assisting medicinal cannabis companies; and
- FreshLeaf Analytics – Australia’s leading source of data and information about the medicinal cannabis industry.
Southern Cannabis Holdings’ director and chief executive officer Tim Drury
Three companies to present
() co-founder and managing director Roby Zomer will also present at the event, along with Zelira Therapeutics () managing director and CEO Richard Hopkins.
The companies will discuss on the global medical cannabis, which is predicted to grow at a compound annual growth rate (CAGR) of 15.4% from 2019 to 2025, and is expected to be worth US$52.35 billion by 2025, according to Market Research Future (MRFR).
To register for the August 11 webinar, please click here.
The webinar will also be live-streamed on the Proactive YouTube channel, which can then be viewed at any time following the presentation.
For additional information, please contact John Phillips at Proactive: [email protected] or 0431 597 771.